Board of Directors

Dr. Nirmal Mulye, Chairman

Nirmal Mulye is the founder of Nostrum. With over 20 years of experience in the specialty/generic pharmaceutical industry, Nirmal is responsible for innovation and development of all of Nostrum’s pharmaceutical products, a portfolio of controlled-release technologies. He has over 10 patents to his credit. Prior thereto, Nirmal served in various research and development positions with Forest Laboratories. He received his B.S. in Pharmacy from Bombay University and Ph.D. from Temple University. His current interests are in the area of healthcare and public policy. He is also currently working with several key innovators in the field of alternative energy and fuels.

Michael T Amato, MBA

President & Chief Executive Officer

Michael Amato currently serves as the President and CEO of InspiRx Inc. Born in Brooklyn, New York, Michael earned his MBA from Bedford University in London, UK. He has over 40 years experience in the medical device industry including several key senior management positions at DHD Medical, Trudell Medical International, and Monaghan Medical Corporation. Michael was most recently Senior Vice President of Special Accounts and Professional relations at TMI/MMC. Prior to this he was Vice President of Sales and Marketing at MMC where he helped position them as the worldwide leader with their Valved-holding chambers used with pressurize Meter Dose Inhalers.

Michael also serves on several boards including nonprofit American Respiratory Care Foundation and The Allergy Asthma Network Mothers of Asthmatics. Michael has also served on the US Food and Drug Administration Device Advisory Panel.

Bruce Regenstreich, Esq.

Bruce Regenstreich, Esq. PLLC, was born in Brooklyn, New York, and is a former Homicide Prosecutor with the Brooklyn District attorney’s office. He has 40 years of experience as a litigator in the Insurance defense field counseling Insurance companies on coverage and liability related cases and has been admitted to the bars of New York, New Jersey, Philadelphia and Massachusetts. As an active litigator since 1976, he currently serves as legal counsel and advisor to Dr. Nirmal Mulye, and has responsibility for general legal issues relating to NPLLC, NLI and other related pharmaceutical companies in the non-IP, Patent and Trademark, field. He has extensive experience in negotiating resolutions in complicated pharmaceutical contract and litigation matters. In addition to his general litigation practice, Bruce is also a Member of several of the Nostrum Pharmaceutical LLC, and related companies Boards of Directors, including InspiRx, Inc.

Bernard J. Berk

Mr. Berk is a Director of InspiRx and serves as President and Vice Chairman of Nostrum Laboratories, Inc., a subsidiary of NPLLC, the parent company of InspiRx. Mr. Berk has served in the generic pharmaceutical industry beginning with Par Pharmaceuticals, Inc., where he was Senior Vice President of Sales, Marketing and Business Development. Thereafter, Mr. Berk was, respectively, President and Chief Executive Officer of Nale Pharmaceutical Corporation (an Elan affiliate) and Chief Executive Officer and Chairman of publicly traded Elite Pharmaceuticals, Inc. Mr. Berk has also served as President and Chief Executive Officer of Michael Andrews Corporation, a pharmaceutical management consultant firm. Mr. Berk holds a B.S. from New York University.